News

Archive by tag: CDX-085Return
RSS
Astaxanthin compound found to switch on the FOX03 'longevity gene' in mice
The University of Hawaii John A. Burns School of Medicine ("JABSOM") and Cardax, Inc. ("Cardax") (OTCQB:CDXI), a Honolulu based life sciences company, have jointly announced the results of an animal study evaluating the effectiveness of a compound that holds promise in anti-aging therapy.
Read More
| Categories: | Tags: genetics, genome modification, genetic engineering, FOXO3, CDX-085 | Comments: (0) | View Count: (948)